## Rotavirus Vaccination & Breakthrough Infection ### Vaccine Schedule & Efficacy **Key Point:** Rotavirus vaccines (RotaTeq, Rotarix) require a **complete primary series** (2–3 doses depending on formulation) to achieve optimal protection. A single dose provides insufficient immunity. ### Vaccine Formulations & Dosing Schedule | Vaccine | Doses | Schedule | Efficacy (complete series) | |---------|-------|----------|---------------------------| | **RotaTeq (RV5)** | 3 doses | 0, 2, 4 months | 98–99% vs severe disease | | **Rotarix (RV1)** | 2 doses | 0, 2 months | 85–98% vs severe disease | | **Single dose (incomplete)** | 1 dose | — | ~50–60% protection | **High-Yield:** The child received only **1 dose 6 weeks ago**. She has not completed the primary immunization series and therefore lacks adequate protection against rotavirus infection. ### Immune Response to Rotavirus Vaccination 1. **First dose:** Priming of mucosal and systemic immunity; modest IgA and IgG responses 2. **Second dose:** Booster response; significant increase in neutralizing antibodies 3. **Third dose (if RV5):** Further enhancement of protective immunity 4. **Incomplete series:** Insufficient neutralizing antibody titers to prevent infection **Clinical Pearl:** Even vaccinated children can develop rotavirus gastroenteritis if the primary series is incomplete. However, vaccinated children typically experience milder disease (fewer stools, shorter duration, less dehydration) compared to unvaccinated children. ### Vaccine Efficacy & Breakthrough Infections **Mnemonic: ROTA-VACS = Requires Optimal Timing, Adequate doses, Vaccination series complete, Achieves protection, Coverage of circulating strains, Serotype-specific immunity** - **Complete series efficacy:** 85–99% against severe rotavirus gastroenteritis - **Incomplete series:** ~50–60% protection; breakthrough infections common - **Breakthrough infections in fully vaccinated children:** Rare (~1–5%) and typically mild - **Strain mismatch:** Less common in India; RotaTeq covers G1–G4; Rotarix covers G1–G4 with cross-protection ### Why Other Options Are Incorrect **Strain mismatch (Option 2):** While rotavirus has multiple G and P serotypes, the available vaccines provide broad coverage of circulating strains globally. Strain mismatch is an uncommon cause of breakthrough infection in a fully vaccinated child. In this case, the child is incompletely vaccinated, making incomplete immunization the primary reason. **Malabsorption (Option 3):** Rotavirus vaccine is live-attenuated and replicates in the intestinal epithelium. Malabsorption would be an extremely rare cause of vaccine failure and would require underlying GI pathology (e.g., celiac disease, cystic fibrosis), which is not suggested by the clinical presentation. **Natural immunity waning (Option 4):** Immunity waning occurs over months to years, not within 6 weeks. Moreover, the child has not yet developed adequate immunity from a single dose. ### Clinical Management - **Supportive care:** ORT, electrolyte correction - **Complete vaccination series:** The child should receive her second (and third, if RV5) dose after recovery to complete the primary series - **Prognosis:** Breakthrough infections in partially vaccinated children are typically mild to moderate; severe dehydration is less common than in unvaccinated children **Warning:** Do not confuse incomplete vaccination (inadequate primary series) with vaccine failure (failure of a complete series to protect). This child has incomplete vaccination.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.